Related Experiment Video
Updated: Feb 18, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
[Hemorrhagic complications of percutaneous interventions for nephrolithiasis]
S V Shkodkin1,2, Yu B Idashkin1,2, V N Dmitriev1,2
1St. Ioasaf Belgorod Regional Hospital, Belgorod, Russia.
Insights
Hemorrhagic complications are a concern in percutaneous nephrolithotripsy. Arterial hypertension is a key risk factor, and correcting it pre-surgery is advised. Image-guided interventions can manage bleeding.
Area of Science:
- Urology
- Nephrology
- Interventional Radiology
Background:
- Hemorrhagic complications are a significant challenge in percutaneous urolithiasis interventions.
- Percutaneous nephrolithotripsy (PCNL) is a common procedure for kidney stone removal.
Purpose of the Study:
- To investigate the incidence of hemorrhagic complications following percutaneous nephrolithotripsy.
- To identify risk factors associated with hemorrhagic complications in PCNL.
Main Methods:
- A comparative analysis of 146 percutaneous nephrolithotripsies was conducted.
- Patients were divided into a study group (staghorn nephrolithiasis) and a control group.
- Demographic data, stone characteristics, operative details, and complication rates were analyzed.
Main Results:
- The incidence of hemorrhagic complications was similar between groups (16-16.9%) and did not exceed Grade II (Clavien-Dindo).
- Higher body weight and body mass index were noted in the study group.
- Arterial hypertension was identified as the primary risk factor for hemorrhagic complications.
Conclusions:
- Correction of arterial hypertension is recommended before percutaneous nephrolithotripsy.
- Image-guided endovascular interventions are effective for managing ongoing renal bleeding post-PCNL.
Abstract:
Hemorrhagic complications are one of the major problems of percutaneous urolithiasis interventions.
Aim:
To investigate the incidence of hemorrhagic complications after percutaneous nephrolithotripsy.
Material And Methods:
This was a comparative analysis of 146 percutaneous nephrolithotripsies. The study group comprised 81 patients with stag horn nephrolithiasis; the rest of the patients were assigned to the control group.
Results:
Both groups were comparable in age and sex (p>0.05). The body weight of the patients in the study group was statistically significantly higher than in the control group, amounting to 94.1+/-15.4 and 68.3+/-9.6 kg, respectively (p<0.05), the body mass index in the study group averaged 45.9+/-7.6 kg/m2 versus 28.5+/-9.4 kg/m2 in the control group (p<0.05). 50.6% of the study group patients had urate urolithiasis. The blood loss depended on operative time and the number of accesses to the kidney. The incidence of hemorrhagic complications did not differ in both groups and was in the range of 16 to 16.9% (p> 0.05). Early hemorrhagic complications did not exceed Grade II, according to Clavien-Dindo classification. Anticoagulant and antiplatelet therapy did not increase the number of hemorrhagic complications. Arterial hypertension was the main risk factor for hemorrhagic complications.
Conclusion:
Arterial hypertension in patients scheduled for percutaneous nephrolithotripsy should be corrected. To stop ongoing renal bleeding, image-guided endovascular interventions should be used.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Urinary Tract Calculi VI: Surgical Management
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Hemodialysis II: Procedure and Complications
Cardiac Catheterization IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

